<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500745</url>
  </required_header>
  <id_info>
    <org_study_id>LAA velocity &amp; LA volume</org_study_id>
    <nct_id>NCT02500745</nct_id>
  </id_info>
  <brief_title>Left Atrial Volume Index and Left Atrial Appendage Flow Velocities</brief_title>
  <official_title>Left Atrial Volume Index and Left Atrial Appendage Flow Velocities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After obtaining a consent, bed side cardiac ultrasonography will be performed for cases&#xD;
      undergoing transesophageal echocardiography to evaluate the correlation between left atrium&#xD;
      volume and left atrial appendage flow velocity which can predict the thrombosis risk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Informed consent will be obtained prior to any research related procedures Prior to&#xD;
      performing the transesophageal echocardiography, 4 and a 2-chamber transthoracic images will&#xD;
      be obtained to perform standard left atrial volumetric assessment as well as speckle tracking&#xD;
      interrogation. Both these procedures will be performed offline. The transesophageal&#xD;
      echocardiography will be performed using available equipment with a 5- to 7-megaHertz&#xD;
      multiplane transducer and according to standard of care. All images will be acquired per&#xD;
      American Society of Echocardiography guidelines and will be recorded for further analysis.&#xD;
      The left atrial appendage will be best visualized in the 60, 90 and 110 degree imaging planes&#xD;
      and left atrial appendage contraction velocity will be recorded by placing a pulsed wave&#xD;
      Doppler sample volume inside the proximal third of the left atrial appendage at each angle.&#xD;
      In addition, images will be recorded using a 3-beat cycle capture to later perform offline&#xD;
      velocity vector imaging analysis for left atrial appendage speckle tracking analysis. The&#xD;
      transthoracic echocardiography will be performed just before the transesophageal&#xD;
      echocardiography examination using a 2- to 4-megaHertz transducer and according to standard&#xD;
      practice guidelines. The following echocardiographic variables will be prospectively measured&#xD;
      and calculated: left ventricle ejection fraction using Simpson method, left atrial volume&#xD;
      will be measured using biplane method and left atrium volume index is calculated based on&#xD;
      body surface area. Tissue Doppler images of mitral valve annulus will be measured and Pulsed&#xD;
      wave Doppler of mitral inflow velocity.&#xD;
&#xD;
      Study does not include follow up. Study duration is up to 24 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between left atrium volume index and Left atrial appendage flow velocity</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Thrombosis of Left Atrial Appendage</condition>
  <arm_group>
    <arm_group_label>Transesophageal echocardiography</arm_group_label>
    <description>Patients referred for transesophageal echocardiography for a clinical indication</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for transesophageal echocardiography&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Study will include all patients 18-80 years of age and referred for transesophageal&#xD;
             evaluation of left atrium or left atrium appendage for appropriate clinical&#xD;
             indications, at the University of Cincinnati University Medical Center and VA Medical&#xD;
             Center.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with either moderate to sever mitral valve disease or previous prosthetic&#xD;
             mitral replacement.&#xD;
&#xD;
          -  Patients with acute heart failure&#xD;
&#xD;
          -  History of previous left atrium appendage surgical intervention.&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Harris</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elsayed Abo-salem</last_name>
    <phone>513-558-1032</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of cincinnati medical center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>September 2, 2014</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <last_update_submitted>July 14, 2015</last_update_submitted>
  <last_update_submitted_qc>July 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Elsayed Abo-Salem</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

